198 related articles for article (PubMed ID: 7942680)
21. [Treatment of Barrett esophagus with argon plasma coagulation with acid suppression--a prospective study].
Martin WR; Jakobs R; Spiethoff A; Maass S; Riemann JF
Z Gastroenterol; 1999 Sep; 37(9):779-84. PubMed ID: 10522363
[TBL] [Abstract][Full Text] [Related]
22. Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus.
Sontag SJ; Schnell TG; Chejfec G; Kurucar C; Karpf J; Levine G
Aliment Pharmacol Ther; 1997 Feb; 11(1):147-56. PubMed ID: 9042987
[TBL] [Abstract][Full Text] [Related]
23. Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus--a pilot study.
Luman W; Lessels AM; Palmer KR
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):627-30. PubMed ID: 8853248
[TBL] [Abstract][Full Text] [Related]
24. Barrett's esophagus: prevalence and size of hiatal hernia.
Cameron AJ
Am J Gastroenterol; 1999 Aug; 94(8):2054-9. PubMed ID: 10445527
[TBL] [Abstract][Full Text] [Related]
25. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.
O'Riordan JM; Byrne PJ; Ravi N; Keeling PW; Reynolds JV
Am J Surg; 2004 Jul; 188(1):27-33. PubMed ID: 15219481
[TBL] [Abstract][Full Text] [Related]
26. High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation.
Mörk H; Al-Taie O; Berlin F; Kraus MR; Scheurlen M
Scand J Gastroenterol; 2007 Jan; 42(1):23-7. PubMed ID: 17190758
[TBL] [Abstract][Full Text] [Related]
27. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
28. Long-term follow-up of Barrett's high-grade dysplasia.
Weston AP; Sharma P; Topalovski M; Richards R; Cherian R; Dixon A
Am J Gastroenterol; 2000 Aug; 95(8):1888-93. PubMed ID: 10950031
[TBL] [Abstract][Full Text] [Related]
29. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus.
Eisen GM; Sandler RS; Murray S; Gottfried M
Am J Gastroenterol; 1997 Jan; 92(1):27-31. PubMed ID: 8995932
[TBL] [Abstract][Full Text] [Related]
30. Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery.
Sampliner RE; Steinbronn K; Garewal HS; Riddell RH
Am J Gastroenterol; 1988 May; 83(5):510-2. PubMed ID: 3364411
[TBL] [Abstract][Full Text] [Related]
31. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
Weston AP; Badr AS; Hassanein RS
Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
[TBL] [Abstract][Full Text] [Related]
32. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
33. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
Triadafilopoulos G; Kaczynska M; Iwane M
Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
[TBL] [Abstract][Full Text] [Related]
34. Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up.
Ackroyd R; Kelty CJ; Brown NJ; Stephenson TJ; Stoddard CJ; Reed MW
Endoscopy; 2003 Jun; 35(6):496-501. PubMed ID: 12783347
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and treatment of Barrett's oesophagus. A general survey.
Petrakis IE; Sciacca V; Iascone C
Acta Chir Belg; 2001; 101(2):53-8. PubMed ID: 11396051
[TBL] [Abstract][Full Text] [Related]
36. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Barrett's esophagus by endoscopic argon plasma coagulation.
Dumoulin FL; Terjung B; Neubrand M; Scheurlen C; Fischer HP; Sauerbruch T
Endoscopy; 1997 Oct; 29(8):751-3. PubMed ID: 9427496
[TBL] [Abstract][Full Text] [Related]
38. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
39. Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus.
Nishi T; Makuuchi H; Weinstein WM
Tokai J Exp Clin Med; 2005 Jul; 30(2):117-21. PubMed ID: 16146202
[TBL] [Abstract][Full Text] [Related]
40. Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy.
Amano Y; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Ishimura N; Furuta K; Ishihara S; Adachi K; Maruyama R; Kinoshita Y
J Gastroenterol Hepatol; 2007 Jun; 22(6):901-7. PubMed ID: 17565646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]